Crossmark

Irinotecan and vincristine for the treatment of refractory desmoplastic small round cell tumor in a developing country: a case report

Crossref DOI link: https://doi.org/10.1186/s13256-019-1985-z

Published Online: 2019-03-10

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ambar, Natalia Brenneken Duarte https://orcid.org/0000-0003-1775-1321
de Seixas Alves, Maria Teresa

Lederman, Henrique Manoel

Abib, Simone

Duarte, Alexandre Alberto Barros

Caran, Eliana Monteiro
License Information

Text and Data Mining valid from 2019-03-10
More Information

Article History

Received: 4 April 2018

Accepted: 17 January 2019

First Online: 10 March 2019

Ethics approval and consent to participate

: This study was submitted to the Ethics and Research Committee of São Paulo Federal University (subscription number: 1.163.762) and the Scientific Committee of Instituto de Oncologia Pediátrica (subscription number: IOP-017/2015). The study was approved and the need of patient’s consent was waived, since it is a retrospective study based on medical records.

: Written informed was obtained from the patient’s legal guardian for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.